These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30239388)

  • 21. [Antineoplastic agents and biologic response modifiers in oncologic hematology].
    Cabrera Marín JR; Briz del Blanco M
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():3-13. PubMed ID: 10422445
    [No Abstract]   [Full Text] [Related]  

  • 22. Optimizing End-of-Life Care for Patients With Hematological Malignancy: Rethinking the Role of Palliative Care Collaboration.
    Cheng HW
    J Pain Symptom Manage; 2015 May; 49(5):e5-6. PubMed ID: 25656326
    [No Abstract]   [Full Text] [Related]  

  • 23. [The experience of disease and treatments among teenagers and young adults with hematological malignancies].
    Polomeni A
    Bull Cancer; 2011 Oct; 98(10):1193-200. PubMed ID: 22008215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges for cancer care delivery to adolescents and young adults: present and future.
    Meeneghan MR; Wood WA
    Acta Haematol; 2014; 132(3-4):414-22. PubMed ID: 25228567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sport coaching for psychological and social recovery after hematological cancer: An innovative perspective].
    Calvin S; Blaise D; Ben Soussan P; Cuvelier S; Cicut N; Caymaris L; Arnault Y; Onesta C; Dantin P; Viens P
    Bull Cancer; 2017 Oct; 104(10):823-830. PubMed ID: 29031507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The irreplaceable image: Nails changes in onco-hematologic patients.
    Vassallo C; Brazzelli V; Ardigò M; Borroni G
    Haematologica; 2001 Mar; 86(3):334-6. PubMed ID: 11255290
    [No Abstract]   [Full Text] [Related]  

  • 27. [Out-patient palliative care of children with cancer and their families].
    Janssen G; Friedland C; Richter U; Leonhardt H; Göbel U
    Klin Padiatr; 2004; 216(3):183-8. PubMed ID: 15175964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.
    Samuelson BT; Gernsheimer T; Estey E; Garcia DA
    Thromb Res; 2016 May; 141():104-5. PubMed ID: 26994682
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fulminant hepatitis B as a result of reactivation in hematologic patient after chemotherapy combined with rituximab].
    Cantudo-Muñoz P; Anguita-Arance MM; Muñoz-Peña C; Amores-Antequera C
    Rev Esp Quimioter; 2015 Feb; 28(1):56-7. PubMed ID: 25690147
    [No Abstract]   [Full Text] [Related]  

  • 30. Postchemotherapy connective tissue diseases--more than just rheumatism?
    Amft N; D'Cruz D
    Lupus; 1996 Aug; 5(4):255-6. PubMed ID: 8869893
    [No Abstract]   [Full Text] [Related]  

  • 31. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
    Littlewood TJ; Nortier J; Rapoport B; Pawlicki M; de Wasch G; Vercammen E; Schuette W; Wils J; Freund M;
    Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gastrointestinal tract is a common target of invasive aspergillosis in patients receiving cytotoxic chemotherapy for hematological malignancy.
    Kami M; Hori A; Takaue Y; Mutou Y
    Clin Infect Dis; 2002 Jul; 35(1):105-6; author reply 106-7. PubMed ID: 12060886
    [No Abstract]   [Full Text] [Related]  

  • 33. Supportive care needs of hematological cancer survivors: a critical review of the literature.
    Hall A; Lynagh M; Bryant J; Sanson-Fisher R
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):102-16. PubMed ID: 23582686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How should we assess patient-reported outcomes in the onco-hematology clinic?
    Cannella L; Efficace F; Giesinger J
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):522-529. PubMed ID: 30239387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Early Palliative Care Interventions in Hematological Malignancies and Bone Marrow Transplant Patients: Barriers and Potential Solutions.
    Ruiz M; Reynolds P; Marranzini R; Khan A; Ketterer J; Brahim A
    Am J Hosp Palliat Care; 2018 Nov; 35(11):1456-1460. PubMed ID: 29699418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The feasibility of early discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cordonnier C
    Haematologica; 2006 Feb; 91(2):150a. PubMed ID: 16461296
    [No Abstract]   [Full Text] [Related]  

  • 37. [Management of treatment-induced pain in paediatric haematology].
    Ben Hamadi D; Calvet C
    Soins Pediatr Pueric; 2015; (285):28-30. PubMed ID: 26183097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival.
    Jaspers A; Baron F; Servais S; Lejeune M; Willems É; Seidel L; Hafraoui K; Bonnet C; Beguin Y
    Am J Hematol; 2015 Sep; 90(9):E197-9. PubMed ID: 26113363
    [No Abstract]   [Full Text] [Related]  

  • 39. Autologous stem cell transplantation in hematological malignancies.
    Gorin NC
    Springer Semin Immunopathol; 2004 Nov; 26(1-2):3-30. PubMed ID: 15480668
    [No Abstract]   [Full Text] [Related]  

  • 40. [Illness experience of adolescents with hematologic malignancies].
    Son SY
    J Korean Acad Nurs; 2011 Oct; 41(5):603-12. PubMed ID: 22143209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.